📢 Your feedback matters! Review and comment on the College of American Pathologists (CAP), International Association for the Study of Lung Cancer, and AMP draft recommendations for #LungCancer molecular testing. Help us improve patient care! 🌟 #MolPath#Oncology#PathTwitter#CancerCare Comment period closes 9/12. https://ow.ly/AWbn50TgBTg
Association for Molecular Pathology (AMP)’s Post
More Relevant Posts
-
MD, Gastroenterology and Digestive Endoscopy Resident, Vita e Salute San Raffaele University, Clinical and Translational researcher in Esophago-Gastric Eosinophilic and Motility disorders
Check out this very interesting study #CRCscreening
The 10-year interval between colonoscopy screenings for colorectal cancer (CRC) could be extended to 15 years in patients with no family history of CRC and negative findings on their first colonoscopy, finds matched cohort study. https://ja.ma/44oE2MR
-
-
Findings suggest that the 10-year interval between colonoscopy screenings for individuals with a first negative colonoscopy for CRC could be safely extended to 15 years, with minimal additional risk of CRC and CRC-specific death. #CRC #cancer #oncology
The 10-year interval between colonoscopy screenings for colorectal cancer (CRC) could be extended to 15 years in patients with no family history of CRC and negative findings on their first colonoscopy, finds matched cohort study. https://ja.ma/3Wb50Ed
-
-
Synthetic lethality has shown great promise in precision cancer medicine, with recent studies demonstrating broader applications and higher success rates compared to other approaches. However, a vast majority of potential targets remain unexplored, hinting at exciting possibilities for even more effective cancer treatments in the future. Read the full paper in Med: https://lnkd.in/ec7xeheT #SLforCancer #PrecisionOncology #FutureofMedicine
-
Early Detection. Early Action. Early Recovery.💕 This #NationalMammographyDay, take a moment to learn about the importance of early breast cancer screening. Early steps can lead to better outcomes. Call: 0731 4206750 / 7880096006 #CHRC #Choithramhospital #BreastCancerAwareness #StayHealthy #EarlyDetectionSavesLives
-
-
At #ESMO24, a Late-Breaking Abstract provides further evidence for the efficacy and tolerability of durvalumab #immunotherapy in limited-stage small cell lung cancer (LS-SCLC). Subgroup analyses from the ADRIATIC trial support the use of immunotherapy, irrespective of prior concurrent chemoradiotherapy and use of prophylactic cranial irradiation. “These data make the possibility of cure a reality for more patients with LS-SCLC, so this is immediately practice-changing and every patient deserves to benefit,” states Stephen Liu. 👇Read his full insights on the #ESMODailyReporter #SCLC https://ow.ly/ZHnu50TmMmT
-
-
Exciting news from ASCO 2024! The latest five-year follow-up results reveal a significant breakthrough in ALK-positive advanced lung cancer, showing prolonged progression-free survival. This milestone is a testament to the advancements in cancer research and treatment. Stay tuned for more updates! #ASCO2024 #LungCancerResearch #MedicalBreakthroughs
-
-
🚨 Breaking news! 🚨 Our Phase 3 study of Trodelvy in metastatic urothelial cancer unfortunately did not meet the primary endpoint. This is a setback, but we remain committed to advancing treatments for patients in need. We will continue to analyze the data and explore potential next steps. Stay tuned for updates. #cancerresearch #clinicaltrials #oncologyinnovation
-
1st ScreenCell® Clinical Trial on #breastcancer🎗 Today, we proudly present to you, in all its details, our first #clinicaltrial on breast cancer in collaboration with Kahia Laboratory and GENETHICAL Discover the details of this study by checking the dedicated carousel ! 📕 #CTCs #personalizedmedicine #precisionmedicine #liquidbiopsy samira kahia tani Nazim Omar Kahia Tani
-
🌟 𝗡𝗲𝘄 𝗥𝗲𝗹𝗲𝗮𝘀𝗲: "𝗪𝗵𝗮𝘁’𝘀 𝗡𝗲𝘄 𝗗𝗼𝗰? 𝗶𝗻 𝗚𝗨 𝗖𝗮𝗻𝗰𝗲𝗿” 🌟 Dive into the latest episode as Prof Emmanuel Seront and Prof Christof Vulsteke discuss the THOR-2 trial's cutting-edge findings for HR NMIBC treatment. Learn how erdafitinib, in patients with positive FGFR alterations, marks a significant leap in managing bladder cancer, offering hope for patients with limited treatment options. 👇 View all WND GU videos - link in the comments! #MediMix #GUCancer #BladderCancer #THOR2Trial #OncologyInnovation
-
Little Rock- Did you know that early screening and diagnosis are crucial for improving long-term survival? Join us on Saturday, June 29, for a small-cell lung cancer educational workshop as we delve into the benefits of early screening, different treatment options, and the life-changing impact of clinical trials. Click the link to register and be a part of this important discussion! https://lnkd.in/eXBymUyJ Amgen #HEAL12 #EarlyDetection #ClinicalTrials #LungCancerAwareness
-
